about
The immunological effect of hyaluronan in tumor angiogenesisLack of the matricellular protein SPARC (secreted protein, acidic and rich in cysteine) attenuates liver fibrogenesis in miceHuman umbilical cord perivascular cells exhibited enhanced migration capacity towards hepatocellular carcinoma in comparison with bone marrow mesenchymal stromal cells: a role for autocrine motility factor receptor.Low molecular weight hyaluronan-pulsed human dendritic cells showed increased migration capacity and induced resistance to tumor chemoattraction.Increased migration of human mesenchymal stromal cells by autocrine motility factor (AMF) resulted in enhanced recruitment towards hepatocellular carcinoma.Inhibition of Hyaluronic Acid Synthesis Suppresses Angiogenesis in Developing Endometriotic Lesions.Tumor Microenvironment Remodeling by 4-Methylumbelliferone Boosts the Antitumor Effect of Combined Immunotherapy in Murine Colorectal Carcinoma.4-methylumbelliferone inhibits hepatocellular carcinoma growth by decreasing IL-6 production and angiogenesis.Pulsing dendritic cells with whole tumor cell lysates.SPARC (secreted protein acidic and rich in cysteine) knockdown protects mice from acute liver injury by reducing vascular endothelial cell damage.Mesenchymal stromal cells engineered to produce IGF-I by recombinant adenovirus ameliorate liver fibrosis in miceEx vivo loading of autologous dendritic cells with tumor antigens.Dendritic cells regulate angiogenesis associated with liver fibrogenesis.[Dendritic cell-based therapeutic cancer vaccines].Co-treatment of tumor cells with hyaluronan plus doxorubicin affects endothelial cell behavior independently of VEGF expressionContribution of neural crest and GLAST+ Wnt1+ bone marrow pericytes with liver fibrogenesis and/or regenerationHyaluronan preconditioning of monocytes/macrophages affects their angiogenic behavior and regulation of TSG-6 expression in a tumor type-specific mannerDetermination of Cell-Surface Hyaluronan Through Flow CytometryImproving the Therapeutic Ability of Mesenchymal Stem/Stromal Cells for the Treatment of Conditions Influenced by Immune CellsSirtuin 1 reduces hyaluronan synthase 2 expression by inhibiting nuclear translocation of NF-κB and expression of the long-noncoding RNA HAS2-AS1The Role of the Tumor Microenvironment in the Development and Progression of Hepatocellular Carcinoma
P50
Q26771483-4F442500-2D57-4B11-897B-8F2CF3F3AFB2Q28486111-FF25BA81-7746-4644-B4FC-EDA089E01C74Q34043094-B640BAC6-6288-439C-8A8C-F549B25B65B8Q34216061-508BAD80-1C0A-4970-9175-D71E7F341F79Q35149319-03CCA8CD-8F36-4E78-9BC3-485EE940FE8DQ35971408-1E200F7E-F310-431A-8D76-CD0A2168C5E9Q36757056-9C8CE799-1442-4441-95B5-88E80C7209D6Q38886114-5B3F5ADC-0950-4A7F-9BB0-90E889599FB7Q39016393-86C1B398-07C9-412F-8179-774C3A553B69Q40111377-482C5EB6-669C-4084-AD87-7267D2EFEA46Q42094086-653B212C-E5A4-4BA3-BACB-EC42A5D6FB4EQ45863210-2826B065-71B1-4891-827B-3AFE47B2C12BQ52882399-005CDF45-D0B8-4DF7-9636-490D4086C4AAQ52886415-C08CB899-34AC-46E7-927D-8DB6D7E540B2Q60050019-99706163-7E3D-4CF7-849B-7F47B1D1B637Q89500085-D3E4292A-C1B6-4EEB-B441-8302A4A86B34Q91682878-542D5DF4-F8C9-461F-8B56-754EDB728A8CQ92065449-E8BDE864-CB68-4C43-9BC5-5F7AC62963A0Q92308105-52404750-157D-4988-BAEA-1EDD2D8FEDEDQ92607821-9C193499-5A53-4020-9CC8-741989FCF0AAQ95583489-1AFF33AF-E755-4EDB-9654-9FBB99CE8DD1
P50
description
investigador
@es
researcher
@en
name
Laura Alaniz
@en
type
label
Laura Alaniz
@en
prefLabel
Laura Alaniz
@en
P31
P496
0000-0002-6070-6078